LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 32

Search options

  1. Article ; Online: p53: master of life, death, and the epigenome.

    Laptenko, Oleg / Prives, Carol

    Genes & development

    2017  Volume 31, Issue 10, Page(s) 955–956

    Abstract: Long understood as a bona fide tumor suppressor that safeguards the integrity of the genome via regulating numerous cellular outcomes, p53 may also exert its decisive and versatile functions by controlling DNA methylation. In this issue ... ...

    Abstract Long understood as a bona fide tumor suppressor that safeguards the integrity of the genome via regulating numerous cellular outcomes, p53 may also exert its decisive and versatile functions by controlling DNA methylation. In this issue of
    MeSH term(s) Animals ; DNA Methylation/genetics ; Epigenesis, Genetic/genetics ; Gene Expression Regulation, Neoplastic ; Tumor Suppressor Protein p53/genetics ; Tumor Suppressor Protein p53/metabolism
    Chemical Substances Tumor Suppressor Protein p53
    Language English
    Publishing date 2017-05-15
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 806684-x
    ISSN 1549-5477 ; 0890-9369
    ISSN (online) 1549-5477
    ISSN 0890-9369
    DOI 10.1101/gad.302364.117
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Anything but simple: a phosphorylation-driven toggle within Brd4 triggers gene-specific transcriptional activation.

    Laptenko, Oleg / Prives, Carol

    Molecular cell

    2013  Volume 49, Issue 5, Page(s) 838–839

    Abstract: In this issue of Molecular Cell, Wu et al. (2013) report their extraordinary findings on the molecular mechanism that controls gene-specific targeting by Brd4, a universal epigenetic reader. ...

    Abstract In this issue of Molecular Cell, Wu et al. (2013) report their extraordinary findings on the molecular mechanism that controls gene-specific targeting by Brd4, a universal epigenetic reader.
    Language English
    Publishing date 2013-03-11
    Publishing country United States
    Document type Comment ; Journal Article
    ZDB-ID 1415236-8
    ISSN 1097-4164 ; 1097-2765
    ISSN (online) 1097-4164
    ISSN 1097-2765
    DOI 10.1016/j.molcel.2013.02.021
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: p53 Frameshift Mutations Couple Loss-of-Function with Unique Neomorphic Activities.

    Tong, David R / Zhou, Wen / Katz, Chen / Regunath, Kausik / Venkatesh, Divya / Ihuegbu, Chinyere / Manfredi, James J / Laptenko, Oleg / Prives, Carol

    Molecular cancer research : MCR

    2021  Volume 19, Issue 9, Page(s) 1522–1533

    Abstract: p53 mutations that result in loss of transcriptional activity are commonly found in numerous types of cancer. While the majority of these are missense mutations that map within the central DNA-binding domain, truncations and/or frameshift mutations can ... ...

    Abstract p53 mutations that result in loss of transcriptional activity are commonly found in numerous types of cancer. While the majority of these are missense mutations that map within the central DNA-binding domain, truncations and/or frameshift mutations can also occur due to various nucleotide substitutions, insertions, or deletions. These changes result in mRNAs containing premature stop codons that are translated into a diverse group of C-terminally truncated proteins. Here we characterized three p53 frameshift mutant proteins expressed from the endogenous
    MeSH term(s) Apoptosis ; Biomarkers, Tumor/genetics ; Bone Neoplasms/genetics ; Bone Neoplasms/pathology ; Cell Cycle ; Cell Movement ; Cell Proliferation ; Colorectal Neoplasms/genetics ; Colorectal Neoplasms/pathology ; Frameshift Mutation ; Gene Expression Regulation, Neoplastic ; Humans ; Loss of Function Mutation ; Osteosarcoma/genetics ; Osteosarcoma/pathology ; Tumor Cells, Cultured ; Tumor Suppressor Protein p53/genetics
    Chemical Substances Biomarkers, Tumor ; TP53 protein, human ; Tumor Suppressor Protein p53
    Language English
    Publishing date 2021-05-27
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2098788-2
    ISSN 1557-3125 ; 1541-7786
    ISSN (online) 1557-3125
    ISSN 1541-7786
    DOI 10.1158/1541-7786.MCR-20-0691
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Anything but Simple: A Phosphorylation-Driven Toggle within Brd4 Triggers Gene-Specific Transcriptional Activation

    Laptenko, Oleg / Prives, Carol

    Molecular cell. 2013 Mar. 07, v. 49

    2013  

    Abstract: In this issue of Molecular Cell, Wu et al. (2013) report their extraordinary findings on the molecular mechanism that controls gene-specific targeting by Brd4, a universal epigenetic reader. ...

    Abstract In this issue of Molecular Cell, Wu et al. (2013) report their extraordinary findings on the molecular mechanism that controls gene-specific targeting by Brd4, a universal epigenetic reader.
    Keywords epigenetics ; genes ; phosphorylation ; transcriptional activation
    Language English
    Dates of publication 2013-0307
    Size p. 838-839.
    Publishing place Elsevier Inc.
    Document type Article
    ZDB-ID 1415236-8
    ISSN 1097-4164 ; 1097-2765
    ISSN (online) 1097-4164
    ISSN 1097-2765
    DOI 10.1016/j.molcel.2013.02.021
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  5. Article ; Online: The p53-HAT connection: PCAF rules?

    Laptenko, Oleg / Prives, Carol

    Cell cycle (Georgetown, Tex.)

    2012  Volume 11, Issue 16, Page(s) 2975–2976

    MeSH term(s) Cyclin-Dependent Kinase Inhibitor p21/metabolism ; Histones/metabolism ; Humans ; Oxidative Stress ; p300-CBP Transcription Factors/metabolism
    Chemical Substances Cyclin-Dependent Kinase Inhibitor p21 ; Histones ; p300-CBP Transcription Factors (EC 2.3.1.48)
    Language English
    Publishing date 2012-08-14
    Publishing country United States
    Document type News ; Comment
    ZDB-ID 2146183-1
    ISSN 1551-4005 ; 1538-4101 ; 1554-8627
    ISSN (online) 1551-4005
    ISSN 1538-4101 ; 1554-8627
    DOI 10.4161/cc.21528
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: The Tail That Wags the Dog: How the Disordered C-Terminal Domain Controls the Transcriptional Activities of the p53 Tumor-Suppressor Protein.

    Laptenko, Oleg / Tong, David R / Manfredi, James / Prives, Carol

    Trends in biochemical sciences

    2016  Volume 41, Issue 12, Page(s) 1022–1034

    Abstract: The p53 tumor suppressor is a transcription factor (TF) that exerts antitumor functions through its ability to regulate the expression of multiple genes. Within the p53 protein resides a relatively short unstructured C-terminal domain (CTD) that ... ...

    Abstract The p53 tumor suppressor is a transcription factor (TF) that exerts antitumor functions through its ability to regulate the expression of multiple genes. Within the p53 protein resides a relatively short unstructured C-terminal domain (CTD) that remarkably participates in virtually every aspect of p53 performance as a TF. Because these aspects are often interdependent and it is not always possible to dissect them experimentally, there has been a great deal of controversy about the CTD. In this review we evaluate the significance and key features of this interesting region of p53 and its impact on the many aspects of p53 function in light of previous and more recent findings.
    MeSH term(s) Amino Acid Sequence ; Animals ; Binding Sites ; DNA/chemistry ; DNA/metabolism ; Humans ; Hydrophobic and Hydrophilic Interactions ; Intrinsically Disordered Proteins/chemistry ; Intrinsically Disordered Proteins/genetics ; Intrinsically Disordered Proteins/metabolism ; Protein Binding ; Protein Conformation, alpha-Helical ; Protein Conformation, beta-Strand ; Protein Domains ; Protein Structure, Tertiary ; Sequence Alignment ; Sequence Homology, Amino Acid ; Transcriptional Activation ; Tumor Suppressor Protein p53/chemistry ; Tumor Suppressor Protein p53/genetics ; Tumor Suppressor Protein p53/metabolism
    Chemical Substances Intrinsically Disordered Proteins ; Tumor Suppressor Protein p53 ; DNA (9007-49-2)
    Language English
    Publishing date 2016-09-23
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 194216-5
    ISSN 1362-4326 ; 0968-0004 ; 0376-5067
    ISSN (online) 1362-4326
    ISSN 0968-0004 ; 0376-5067
    DOI 10.1016/j.tibs.2016.08.011
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: The Tail That Wags the Dog: How the Disordered C-Terminal Domain Controls the Transcriptional Activities of the p53 Tumor-Suppressor Protein

    Laptenko, Oleg / Tong, David R / Manfredi, James / Prives, Carol

    Trends in biochemical sciences. 2016 Dec., v. 41, no. 12

    2016  

    Abstract: The p53 tumor suppressor is a transcription factor (TF) that exerts antitumor functions through its ability to regulate the expression of multiple genes. Within the p53 protein resides a relatively short unstructured C-terminal domain (CTD) that ... ...

    Abstract The p53 tumor suppressor is a transcription factor (TF) that exerts antitumor functions through its ability to regulate the expression of multiple genes. Within the p53 protein resides a relatively short unstructured C-terminal domain (CTD) that remarkably participates in virtually every aspect of p53 performance as a TF. Because these aspects are often interdependent and it is not always possible to dissect them experimentally, there has been a great deal of controversy about the CTD. In this review we evaluate the significance and key features of this interesting region of p53 and its impact on the many aspects of p53 function in light of previous and more recent findings.
    Keywords amino acid sequences ; dogs ; genes ; transcription (genetics) ; transcription factors
    Language English
    Dates of publication 2016-12
    Size p. 1022-1034.
    Publishing place Elsevier Ltd
    Document type Article
    ZDB-ID 194220-7
    ISSN 0968-0004 ; 0376-5067
    ISSN 0968-0004 ; 0376-5067
    DOI 10.1016/j.tibs.2016.08.011
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  8. Article: Transcriptional regulation by p53: one protein, many possibilities.

    Laptenko, O / Prives, C

    Cell death and differentiation

    2006  Volume 13, Issue 6, Page(s) 951–961

    Abstract: The p53 tumor suppressor protein is a DNA sequence-specific transcriptional regulator that, in response to various forms of cellular stress, controls the expression of numerous genes involved in cellular outcomes including among others, cell cycle arrest ...

    Abstract The p53 tumor suppressor protein is a DNA sequence-specific transcriptional regulator that, in response to various forms of cellular stress, controls the expression of numerous genes involved in cellular outcomes including among others, cell cycle arrest and cell death. Two key features of the p53 protein are required for its transcriptional activities: its ability to recognize and bind specific DNA sequences and to recruit both general and specialized transcriptional co-regulators. In fact, multiple interactions with co-activators and co-repressors as well as with the components of the general transcriptional machinery allow p53 to either promote or inhibit transcription of different target genes. This review focuses on some of the salient features of the interactions of p53 with DNA and with factors that regulate transcription. We discuss as well the complexities of the functional domains of p53 with respect to these interactions.
    MeSH term(s) Animals ; Apoptosis Regulatory Proteins/genetics ; Apoptosis Regulatory Proteins/metabolism ; Cell Cycle Proteins/genetics ; Cell Cycle Proteins/metabolism ; DNA/genetics ; DNA/metabolism ; Humans ; Protein Conformation ; Response Elements/genetics ; Transcription, Genetic ; Transcriptional Activation ; Tumor Suppressor Protein p53/chemistry ; Tumor Suppressor Protein p53/metabolism
    Chemical Substances Apoptosis Regulatory Proteins ; Cell Cycle Proteins ; Tumor Suppressor Protein p53 ; DNA (9007-49-2)
    Language English
    Publishing date 2006-06
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 1225672-9
    ISSN 1350-9047
    ISSN 1350-9047
    DOI 10.1038/sj.cdd.4401916
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: p53 binding to nucleosomes within the p21 promoter in vivo leads to nucleosome loss and transcriptional activation.

    Laptenko, Oleg / Beckerman, Rachel / Freulich, Ella / Prives, Carol

    Proceedings of the National Academy of Sciences of the United States of America

    2011  Volume 108, Issue 26, Page(s) 10385–10390

    Abstract: It is well established that p53 contacts DNA in a sequence-dependent manner in order to transactivate its myriad target genes. Yet little is known about how p53 interacts with its binding site/response element (RE) within such genes in vivo in the ... ...

    Abstract It is well established that p53 contacts DNA in a sequence-dependent manner in order to transactivate its myriad target genes. Yet little is known about how p53 interacts with its binding site/response element (RE) within such genes in vivo in the context of nucleosomal DNA. In this study we demonstrate that both distal (5') and proximal (3') p53 REs within the promoter of the p21 gene in unstressed HCT116 colon carcinoma cells are localized within a region of relatively high nucleosome occupancy. In the absence of cellular stress, p53 is prebound to both p21 REs within nucleosomal DNA in these cells. Treatment of cells with the DNA-damaging drug doxorubicin or the p53 stabilizing agent Nutlin-3, however, is accompanied by p53-dependent subsequent loss of nucleosomes associated with such p53 REs. We show that in vitro p53 can bind to mononucleosomal DNA containing the distal p21 RE, provided the binding site is not close to the diad center of the nucleosome. In line with this, our data indicate that the p53 distal RE within the p21 gene is located close to the end of the nucleosome. Thus, low- and high-resolution mapping of nucleosome boundaries around p53 REs within the p21 promoter have provided insight into the mechanism of p53 binding to its sites in cells and the consequent changes in nucleosome occupancy at such sites.
    MeSH term(s) Cell Line, Tumor ; Colonic Neoplasms/metabolism ; Colonic Neoplasms/pathology ; DNA/metabolism ; Humans ; Nucleosomes/metabolism ; Promoter Regions, Genetic ; Protein Binding ; Proto-Oncogene Proteins p21(ras)/genetics ; Transcriptional Activation ; Tumor Suppressor Protein p53/metabolism
    Chemical Substances Nucleosomes ; TP53 protein, human ; Tumor Suppressor Protein p53 ; DNA (9007-49-2) ; Proto-Oncogene Proteins p21(ras) (EC 3.6.5.2)
    Language English
    Publishing date 2011-05-23
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 209104-5
    ISSN 1091-6490 ; 0027-8424
    ISSN (online) 1091-6490
    ISSN 0027-8424
    DOI 10.1073/pnas.1105680108
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: p53 binding to nucleosomes within the p21 promoter in vivo leads to nucleosome loss and transcriptional activation

    Laptenko, Oleg / Beckerman, Rachel / Freulich, Ella / Prives, Carol

    Proceedings of the National Academy of Sciences of the United States of America. 2011 June 28, v. 108, no. 26

    2011  

    Abstract: It is well established that p53 contacts DNA in a sequence-dependent manner in order to transactivate its myriad target genes. Yet little is known about how p53 interacts with its binding site/response element (RE) within such genes in vivo in the ... ...

    Abstract It is well established that p53 contacts DNA in a sequence-dependent manner in order to transactivate its myriad target genes. Yet little is known about how p53 interacts with its binding site/response element (RE) within such genes in vivo in the context of nucleosomal DNA. In this study we demonstrate that both distal (5') and proximal (3') p53 REs within the promoter of the p21 gene in unstressed HCT116 colon carcinoma cells are localized within a region of relatively high nucleosome occupancy. In the absence of cellular stress, p53 is prebound to both p21 REs within nucleosomal DNA in these cells. Treatment of cells with the DNA-damaging drug doxorubicin or the p53 stabilizing agent Nutlin-3, however, is accompanied by p53-dependent subsequent loss of nucleosomes associated with such p53 REs. We show that in vitro p53 can bind to mononucleosomal DNA containing the distal p21 RE, provided the binding site is not close to the diad center of the nucleosome. In line with this, our data indicate that the p53 distal RE within the p21 gene is located close to the end of the nucleosome. Thus, low- and high-resolution mapping of nucleosome boundaries around p53 REs within the p21 promoter have provided insight into the mechanism of p53 binding to its sites in cells and the consequent changes in nucleosome occupancy at such sites.
    Keywords DNA ; binding sites ; colorectal neoplasms ; doxorubicin ; genes ; neoplasm cells ; nucleosomes ; transcriptional activation
    Language English
    Dates of publication 2011-0628
    Size p. 10385-10390.
    Publishing place National Academy of Sciences
    Document type Article
    ZDB-ID 209104-5
    ISSN 1091-6490 ; 0027-8424
    ISSN (online) 1091-6490
    ISSN 0027-8424
    DOI 10.1073/pnas.1105680108
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

To top